U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968871) titled 'Ameliorated Pap Tests and Cervical Cancer Screening Participation' on April 27.
Brief Summary: The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation in women who are never screened or under-screened (with an increased risk of invasive cervical cancer).
The present project is the first multicenter randomi...